Skip to main content

Advertisement

Table 2 Increased OR values in the Interphone studies on relationships between MP use and head tumours.

From: Mobile phones and head tumours. The discrepancies in cause-effect relationships in the epidemiological studies - how do they arise?

Author (tumour type) year ref. years MP use total tumours cases/controls and OR (95%CI) ipsilateral tumours cases/controls and OR (95%CI) contralateral tumours cases/controls and OR (95%CI)
Lonn et al. 2004 40 since ≥ 10 14/29 1.9 (0.9-4.1) 12/15 3.9 (1.6-9.5) 4/17 0.8 (0.2-2.9)
(acoustic neuromas)    for ≥ 10 11/26 1.6 (0.7-3.6) 9/12 3.1 (1.2-8.4) 4/16 0.8 (0.2-3.1)
Schoemaker et al. 2005   43 since ≥ 10 47/212 1.0 (0.7-1.5) 31/124 1.3 (0.8-2.0) 20/105 1.0 (0.6-1.7)
(acoustic neuromas)    for ≥ 10 31/131 1.1 (0.7-1.8) 23/72 1.8 (1.1-3.1) 12/73 0.9 (0.5-1.8)
Lonn et al. 2005 41 since ≥ 10 25/38 0.9 (0.5-1.5) 15/18 1.6 (0.8-3.4) 11/25 0.7 (0.3-1.5)
(gliomas)    for ≥ 10 22/33 0.9 (0.5-1.6) 14/15 1.8 (0.8-3.9) 9/23 0.6 (0.3-1.4)
(meningiomas)    since ≥ 10 12/36 0.9 (0.4-1.9) 5/18 1.3 (0.5-3.9) 3/22 0.5 (0.1-1.7)
    for ≥ 10 8/32 0.7 (0.3-1.6) 4/15 1.4 (0.4-4.4) 3/23 0.5 (0.1-1.8)
Hepworth et al. 2006 46 since ≥ 10 66/112 0.9 (0.6-1.3)     
(gliomas)    for ≥ 10 48/67 1.14 (0.74-1.73)     
    regular use    278/486 1.24 (1.02-1.52) 199/491 0.75 (0.61-0.93)
Schuz et al. 2006 47 females only ≥ 0.5 30/38 1.96 (1.1-3.5)     
(gliomas)          
Lonn et al. 2006 48 since ≥ 10 7/15 1.4 (0.5-3.9) 6/9 2.6 (0.9-7.9) 1/9 0.3 (0.0-2.3)
(parotid gland tumours)    for ≥ 10 5/13 1.1 (0.4-3.6) 4/8 2.0 (0.5-7.0) 1/8 0.3 (0.0-2.6)
Klaeboe et al. 2007 49 since ≥ 6 70/73 0.8 (0.5-1.2) 39/37 1.3 (0.8-2.1) 32/42 0.8 (0.5-1.4)
(gliomas)    for ≥ 6 55/61 0.7 (0.4-1.2) 30/30 1.2 (0.7-2.1) 27/34 0.9 (0.5-1.5)
Lahkola et al. 2007 50 since ≥ 10 143/220 0.95 (0.74-1.23) 77/117 1.39 (1.01-1.92) 67/121 0.98 (0.71-1.37)
(gliomas)    for ≥ 10 88/134 0.94 (0.69-1.78) 43/74 1.14 (0.76-1.72) 41/71 1.01 (0.67-1.53)
Lahkola et al. 2008 54 since ≥ 10 73/212 0.91 (0.67-1.25) 33/113 1.05 (0.67-1.65) 24/117 0.62 (0.38-1.03)
(meningiomas)    for ≥ 10 42/130 0.85 (0.57-1.26) 21/73 0.99 (0.57-1.73) 13/68 0.64 (0.33-1.23)
Interphone 2010 72 ≥ 1640 calls 160/113 1.82 (1.15-2.89) 100/62 1.96 (1.22-3.16) 39/31 1.25 (0.64-2.42)
(gliomas)          
Sadetzki et al. 2008 53 > 5479 calls 86/157 1.13 (0.79-1.61) 121/159 1.58 (1.11-2.24) 46/135 0.78 (0.51-1.19)
(parotid gland tumours)    > 266.3 hours 80/155 1.03 (0.72-1.47) 115/158 1.49 (1.05-2.13) 48/129 0.84 (0.55-1.28)
    > 5479 calls <5-year latency 47/82 1.16 (0.74-1.82) 35/40 1.80 (1.05-3.10) 12/41 0.63 (0.31-1.30)
"   > 5479 calls >5-year latency 120/215 1.08 (0.77-1.50) 86/119 1.50 (1.03-2.20) 34/94 0.84 (0.52-1.34)
only regular users > 5479 calls 86/157 1.48 (1.05-2.10)     
" > 18997 calls 81/140 1.51 (1.05-2.17)     
" > 1035 cumulative calls 83/134 1.50 (1.04-2.16)     
    ≥ 18997 calls, urban areas 49/99 1.00 (0.65-1.55)     
    " rural areas 32/41 1.81 (1.04-3.14)     
    ≥ 1035 hours, urban areas 51/96 1.02 (0.67-1.58)     
    " rural areas 32/38 1.96 (1.11-3.44)     
  1. 95% s.s. data